Vital Signs

This week's collection of news and events from the School of Medicine

UNC School of Medicine NIH Funding Jumps More Than $23 Million  in Federal FY 2019

UNC School of Medicine NIH Funding Jumps More Than $23 Million in Federal FY 2019

All six basic science departments rank in the top 10 in National Institutes of Health funding, according to a new report by the Blue Ridge Institute for Medical Research, and 12 clinical departments rank in the top 30.

UNC School of Medicine NIH Funding Jumps More Than $23 Million in Federal FY 2019 - Read More…

UNC Health Care is now “UNC Health”

UNC Health Care is now “UNC Health”

The UNC Health system introduced a new name, new logo, and new commitment to transformational change.

UNC Health Care is now “UNC Health” - Read More…

Researchers implicate gene in DNA errors in aggressive breast cancer

Researchers implicate gene in DNA errors in aggressive breast cancer

Researchers led by UNC Lineberger Comprehensive Cancer Center’s Gaorav Gupta, MD, PhD, described the role of a mutation in the Mre11 gene in triple negative breast cancer and how a disruption of Mre11 function plays a significant role in the genomic instability of that cancer type.

Researchers implicate gene in DNA errors in aggressive breast cancer - Read More…

UNC School of Medicine Announces New Class of FIRST Scholars

UNC School of Medicine Announces New Class of FIRST Scholars

The Fully Integrated Readiness for Service Training (FIRST) is a three-year medical school curriculum to fast-track UNC School of Medicine students into UNC Family Medicine Residency, followed by three years of service in NC with ongoing support in practice.

UNC School of Medicine Announces New Class of FIRST Scholars - Read More…

A New Jetlag Drug? Scientists Create Selective Molecules to Bind to Melatonin Receptors

A New Jetlag Drug? Scientists Create Selective Molecules to Bind to Melatonin Receptors

Researchers from the UNC School of Medicine, UC San Francisco, and the University of Buffalo used 3-D computer simulations and pharmacological experiments to create molecules that selectively target the MT1 melatonin receptor to modulate the biological clocks in animal models of jet lag. Bryan L. Roth, MD, PhD, is co-senior author.

A New Jetlag Drug? Scientists Create Selective Molecules to Bind to Melatonin Receptors - Read More…

Approval Processes for Clinical Practice Guidelines Introduce Potential Conflicts of Interest, Review Finds

Approval Processes for Clinical Practice Guidelines Introduce Potential Conflicts of Interest, Review Finds

The study led by UNC’s Jeffrey Sonis, MD, MPH, in the departments of social medicine and family medicine, finds that most of the approval processes used by medical specialty societies in the U.S. have the potential to undermine editorial independence of the guideline development committee.

Approval Processes for Clinical Practice Guidelines Introduce Potential Conflicts of Interest, Review Finds - Read More…